"Hepatitis C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Descriptor ID |
D006526
|
| MeSH Number(s) |
C02.440.440 C02.782.350.350 C06.552.380.705.440
|
| Concept/Terms |
Hepatitis C- Hepatitis C
- Parenterally-Transmitted Non-A, Non-B Hepatitis
- Parenterally Transmitted Non A, Non B Hepatitis
- PT-NANBH
- Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis C".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis C".
This graph shows the total number of publications written about "Hepatitis C" by people in this website by year, and whether "Hepatitis C" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 6 | 2 | 8 |
| 1998 | 5 | 0 | 5 |
| 1999 | 5 | 2 | 7 |
| 2000 | 6 | 0 | 6 |
| 2001 | 7 | 1 | 8 |
| 2002 | 8 | 2 | 10 |
| 2003 | 3 | 1 | 4 |
| 2004 | 4 | 1 | 5 |
| 2005 | 5 | 4 | 9 |
| 2006 | 5 | 1 | 6 |
| 2007 | 4 | 0 | 4 |
| 2008 | 2 | 1 | 3 |
| 2009 | 4 | 1 | 5 |
| 2010 | 6 | 2 | 8 |
| 2011 | 7 | 3 | 10 |
| 2012 | 7 | 4 | 11 |
| 2013 | 11 | 0 | 11 |
| 2014 | 8 | 2 | 10 |
| 2015 | 7 | 0 | 7 |
| 2016 | 2 | 0 | 2 |
| 2017 | 7 | 2 | 9 |
| 2018 | 7 | 1 | 8 |
| 2019 | 7 | 0 | 7 |
| 2020 | 5 | 0 | 5 |
| 2021 | 6 | 0 | 6 |
| 2022 | 7 | 0 | 7 |
| 2023 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis C" by people in Profiles.
-
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis. Viruses. 2023 09 29; 15(10).
-
Development of a predictive model for identifying women vulnerable to HIV in Chicago. BMC Womens Health. 2023 Jun 16; 23(1):313.
-
How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States. Int J Drug Policy. 2023 02; 112:103930.
-
HepCCATT: a multilevel intervention for hepatitis C among vulnerable populations in Chicago. J Public Health (Oxf). 2022 12 01; 44(4):891-899.
-
Transcriptional Inhibition of MicroRNA miR-122 by Small Molecules Reduces Hepatitis C Virus Replication in Liver Cells. J Med Chem. 2022 12 22; 65(24):16338-16352.
-
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma. Cancer. 2022 10 01; 128(19):3470-3478.
-
HCC Mortality Trends-In with ALD (and NAFLD) and Out with HCV. Dig Dis Sci. 2022 08; 67(8):3483-3484.
-
Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago. PLoS One. 2022; 17(3):e0264983.
-
The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients. Transplantation. 2022 02 01; 106(2):e166.
-
People who inject drugs in metropolitan Chicago: A meta-analysis of data from 1997-2017 to inform interventions and computational modeling toward hepatitis C microelimination. PLoS One. 2022; 17(1):e0248850.